• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Vyluma Meets With FDA On Atropine Sulfate For Pediatric Myopia

    GLOBENEWSWIRE

    Vyluma Announces MAA Validation For European Union

    GLOBENEWSWIRE

    Vyluma Announces Positive Results From Phase III CHAMP Study of NVK002

    GLOBENEWSWIRE

    Vyluma Announces FDA Acceptance of New Drug Application for NVK002

    GLOBENEWSWIRE

    Vyluma to Present at the 41st Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Vyluma Announces Positive Results From Phase III CHAMP Study of NVK002

    GLOBENEWSWIRE

    Vyluma Completes Last Patient Visit for Primary Analysis of Pivotal Phase III

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.